Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katzenstein

Showing results (861-870 of 874) with videos related to

Pageof 88
Sort By:
Plos Medicine|April 21, 2005
Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaborationRami Kantor, David A Katzenstein, Brad Efron, et al.
Eclinicalmedicine|May 31, 2019
Trends in Pretreatment HIV-1 Drug Resistance in Antiretroviral Therapy-naive Adults in South Africa, 2000-2016: A Pooled Sequence AnalysisBenjamin Chimukangara, Richard J Lessells, Soo-Yon Rhee, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|November 28, 2006
Bayesian network analysis of resistance pathways against HIV-1 protease inhibitorsK Deforche, R Camacho, Z Grossman, et al.
Journal of Hepatology|May 16, 2022
Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adultsPavel Sumazin, Tricia L Peters, Stephen F Sarabia, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2006
Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependentJoke Snoeck, Rami Kantor, Robert W Shafer, et al.
Annals of Internal Medicine|November 6, 2001
Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient dataJ P Ioannidis, P S Rosenberg, J J Goedert, et al.
Plos One|December 31, 2015
HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance TestingSoo-Yon Rhee, Michael R Jordan, Elliot Raizes, et al.
Nature Medicine|September 30, 2025
Prevention of type 2 diabetes through prediabetes remission without weight lossArvid Sandforth, Elsa Vazquez Arreola, Robert L Hanson, et al.
The Lancet. Diabetes & Endocrinology|September 28, 2023
Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS)Arvid Sandforth, Reiner Jumpertz von Schwartzenberg, Elsa Vazquez Arreola, et al.
Nature|December 4, 2015
Sustainable HIV treatment in Africa through viral-load-informed differentiated care, Andrew Phillips, Amir Shroufi, et al.
Pageof 88

Showing results (861-870 of 874) with videos related to

Sort By:
Pageof 88
Plos Medicine|April 21, 2005
Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaborationRami Kantor, David A Katzenstein, Brad Efron, et al.
Eclinicalmedicine|May 31, 2019
Trends in Pretreatment HIV-1 Drug Resistance in Antiretroviral Therapy-naive Adults in South Africa, 2000-2016: A Pooled Sequence AnalysisBenjamin Chimukangara, Richard J Lessells, Soo-Yon Rhee, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|November 28, 2006
Bayesian network analysis of resistance pathways against HIV-1 protease inhibitorsK Deforche, R Camacho, Z Grossman, et al.
Journal of Hepatology|May 16, 2022
Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adultsPavel Sumazin, Tricia L Peters, Stephen F Sarabia, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2006
Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependentJoke Snoeck, Rami Kantor, Robert W Shafer, et al.
Annals of Internal Medicine|November 6, 2001
Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient dataJ P Ioannidis, P S Rosenberg, J J Goedert, et al.
Plos One|December 31, 2015
HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance TestingSoo-Yon Rhee, Michael R Jordan, Elliot Raizes, et al.
Nature Medicine|September 30, 2025
Prevention of type 2 diabetes through prediabetes remission without weight lossArvid Sandforth, Elsa Vazquez Arreola, Robert L Hanson, et al.
The Lancet. Diabetes & Endocrinology|September 28, 2023
Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS)Arvid Sandforth, Reiner Jumpertz von Schwartzenberg, Elsa Vazquez Arreola, et al.
Nature|December 4, 2015
Sustainable HIV treatment in Africa through viral-load-informed differentiated care, Andrew Phillips, Amir Shroufi, et al.
Pageof 88